SynapDx Licenses Gene Expression Technology from Children's Hospital Boston

The technology will be used to develop blood-based tests for the early detection of autism spectrum disorders.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories